Aspirin and cancer risk: an updated quantitative review to 2005
about
Nonsteroidal anti-inflammatories (NSAIDs) and aspirin for intestinal metaplasia of the stomachAspirin intake and survival after breast cancerProspective evaluation of analgesic use and risk of renal cell cancerThe biological complexity of colorectal cancer: insights into biomarkers for early detection and personalized careAspirin and lung cancer risk in a cohort study of women: dosage, duration and latencyCyclooxygenase-2 and cancer treatment: understanding the risk should be worth the rewardCardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological preventionNonsteroidal anti-inflammatory drugs and risk for ovarian and endometrial cancers in the Iowa Women's Health StudyAnalgesic use and sex steroid hormone concentrations in postmenopausal women.Decreased risk of squamous cell carcinoma of the head and neck in users of nonsteroidal anti-inflammatory drugsPlatelets and cancer: a casual or causal relationship: revisited.Effect of COX-2 inhibitors and other non-steroidal inflammatory drugs on breast cancer risk: a meta-analysis.Contemporary epidemiology of renal cell cancerDose-risk and duration-risk relationships between aspirin and colorectal cancer: a meta-analysis of published cohort studies.Analgesic use during pregnancy and risk of infant leukaemia: a Children's Oncology Group studyAspirin and urologic cancer risk: an update.Non-steroidal anti-inflammatory drugs use is associated with reduced risk of inflammation-associated cancers: NIH-AARP studyEmerging roles of the microbiome in cancer.Epidemiological study of prostate cancer (EPICAP): a population-based case-control study in FranceAspirin use and the risk of prostate cancer: a meta-analysis of 24 epidemiologic studies.Non-steroidal anti-inflammatory drugs and cancer incidence by sex in the VITamins And Lifestyle (VITAL) cohortUse of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and postmenopausal breast cancer incidenceNuclear factor-erythroid 2-related factor 2 as a chemopreventive target in colorectal cancer.Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health StudyInverse association of NSAID use and ovarian cancer in relation to oral contraceptive use and parity.Prostaglandin E2 EP receptors as therapeutic targets in breast cancer.Analgesic use in relation to sex hormone and prolactin concentrations in premenopausal womenC-reactive protein genotypes and haplotypes, polymorphisms in NSAID-metabolizing enzymes, and risk of colorectal polypsNo association between cyclooxygenase-2 and uridine diphosphate glucuronosyltransferase 1A6 genetic polymorphisms and colon cancer risk.Use of nonsteroidal antiinflammatory agents and incidence of ovarian cancer in 2 large prospective cohorts.Regular aspirin use and breast cancer risk in US Black women.Aspirin and age related macular degeneration; the possible relationship.Analgesic use and patterns of estrogen metabolism in premenopausal women.Aspirin and cancer: has aspirin been overlooked as an adjuvant therapy?Nonsteroidal anti-inflammatory drugs and risk of ovarian cancer: systematic review and meta-analysis of observational studies.BRCA1 and BRCA2 mutations and the risk for colorectal cancer.The role of aspirin in preventing colorectal cancer.PGE2 production in oral cancer cell lines is COX-2-dependent.Breast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysis.Modulation of breast cancer risk by nonsteroidal anti-inflammatory drugs.
P2860
Q24235197-9D8EE1A9-180F-4BBD-A1EE-C8B798D917A6Q24604280-D057C37A-666D-42A6-AFD7-09542C9CC646Q24608512-46FB4B76-EA85-4B7C-A77B-738934B63448Q28066460-3B010DA4-FCEC-4457-BE40-C216F010A3D4Q28222207-2E149FAC-0279-46D2-8B0B-4D3851382523Q28274081-083FE6CC-9211-4060-A948-565C019E7657Q33574045-9B83FA56-D6D6-4B64-ADA5-7A548A5694FFQ33645700-5BB5EFC7-4DEE-4D02-ABAA-CF6B2C7D30A3Q33780860-466BBD9B-A3A4-4DAD-961C-19122F819FBAQ33984604-92530840-A23E-4F48-BB68-D74FD997C937Q34294719-A8689202-C10C-48A6-99C9-861BCA32A03DQ34458235-7DAC86D3-B3C5-4752-B246-E0528FF60973Q34598015-0D3D8781-74A4-4523-ACCA-984EFEAEE5A7Q34603649-F3E77A4B-A10F-47DE-AAF5-C7383565EDA7Q34627781-EBF88338-123A-4C9C-81EC-726F202D7129Q34635300-B84FA167-4274-4392-86A5-9CBED261E919Q34797536-B0DCD413-6EF3-492C-A726-DA106DBF67E5Q35058372-D80CD427-2BC5-481E-87AD-28BD28E742FAQ35098158-C9AA7F35-7139-4E9E-BD68-AF963B55FC05Q35136401-B2BC2B78-A1E0-4986-89A5-8710D45BA7A0Q35869220-62FF920A-070E-4FD8-88F2-527621B58909Q36267669-7752155D-32BF-49B1-914F-9930DA64EEE5Q36301764-70622969-2BED-4E44-88F1-17C8782636DDQ36678729-A5EE6933-C550-4B3D-A0A3-9937AC4783ADQ36696528-B9F50577-ECA6-495C-A60F-38EF95F8C808Q36806255-3394ABE3-B92A-4658-80A6-8F72431394A8Q36824033-7008A183-4E24-4CD0-8FE6-61BCEB767B02Q36950564-01ED4905-19B3-4C4E-8F28-9A25D11E52C1Q37192639-9B4C70E9-24EB-45E4-93AA-F1742BED13B2Q37306176-7C9AF051-8748-4FB7-B715-2858CDC28FBAQ37324216-ECF2E8D6-E940-4567-B969-A38A2B26A852Q37612368-348A4392-9FC0-4A83-AB87-A6EE224D3F4CQ37686568-36619540-9DCC-4441-A6DC-1B0709689343Q37918745-46B01BD5-26DD-43E1-BC38-6317D0879636Q38067425-8C30ACAF-693B-40A1-A52D-9D2AE3170B2DQ38246631-85595B00-3B11-4E86-B480-49F771E4EB4EQ38932550-46E8E50E-F1E5-4353-BEB9-7AFED8158501Q39874240-F1E1846E-D9AF-4197-92EF-8673F8135C97Q40038248-CBCE7A11-310B-4A45-B7AB-2774B357754FQ43061636-BDE4C303-2FC9-4186-AFB9-6C5A652BAA40
P2860
Aspirin and cancer risk: an updated quantitative review to 2005
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Aspirin and cancer risk: an updated quantitative review to 2005
@ast
Aspirin and cancer risk: an updated quantitative review to 2005
@en
Aspirin and cancer risk: an updated quantitative review to 2005
@nl
type
label
Aspirin and cancer risk: an updated quantitative review to 2005
@ast
Aspirin and cancer risk: an updated quantitative review to 2005
@en
Aspirin and cancer risk: an updated quantitative review to 2005
@nl
prefLabel
Aspirin and cancer risk: an updated quantitative review to 2005
@ast
Aspirin and cancer risk: an updated quantitative review to 2005
@en
Aspirin and cancer risk: an updated quantitative review to 2005
@nl
P2860
P50
P1476
Aspirin and cancer risk: an updated quantitative review to 2005
@en
P2093
Cristina Bosetti
P2860
P2888
P304
P356
10.1007/S10552-006-0033-7
P407
P577
2006-09-01T00:00:00Z